Sanofi : Des paris plus ambitieux pour ne pas rater une seconde vague d’innovation
>Une journée R&D pour détailler sa feuille de route - Sanofi organisait hier sa journée R&D qui avait pour principal objectif de donner les grandes lignes de sa stratégie LT. Le track-record de la société pousse les investisseurs à être prudents quant à la réussite du pipeline et au pire sceptiques de considérer Sanofi comme Dupixent dépendant. Nous ne n'attendons pas de révisions significatives des chiffres à l'issue de cette journée mais à un sentiment de plus en pl...Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.